相关实验视频
Updated: Mar 14, 2026

10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
11.8K
强化老年抗生素的作用
1Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4L8, Canada.
Cell
|October 8, 2016
概括
艾维卡兹 (Avycaz) 是一种结合塞夫塔齐和阿维巴克坦的药物,可以对抗细菌感染. 艾维巴克坦可以保护塞夫塔齐免受细菌酶的影响,从而克服耐药性.
科学领域:
- 微生物学
- 药理学
- 传染性疾病
背景情况:
- 细菌感染对全球健康构成重大威胁.
- 抗生素耐药性,特别是由于β-乳糖酶,是一个越来越大的挑战.
- 塞法胺是一种对许多格拉姆阴性细菌有效的头类抗生素.
研究的目的:
- 描述Avycaz (ceftazidime- avibactam) 的作用机制.
- 解释阿维巴克坦如何克服β-乳糖酶介导的抗药性.
- 强调青素结合蛋白 (PBPs) 在抗生素疗效中的作用.
主要方法:
- 这项研究重点是Avycaz成分与细菌点之间的生化相互作用.
- 它详细介绍了阿维巴克坦对β- 乳酸酶的抑制.
- 它描述了Ceftazidime与PBPs的结合,这对于细菌细胞壁的合成至关重要.
主要成果:
- 通过PBPs向细菌细胞壁合成的Avycaz与阿维巴克坦结合使用.
- 艾维巴克坦作为β- 乳糖酶抑制剂,可以防止塞夫塔齐的失活.
- 这种组合恢复了对产生β- 乳酸酶的细菌的疗效.
结论:
- 艾维卡兹代表了一种针对耐药细菌感染的新疗法.
- 该组合有效中和由β- 乳酸酶介导的细菌耐药机制.
- 这种方法增强了已知抗生素的效用,
相关概念视频
Antibiotic Selection
61.8K
Overview
61.8K
Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
Development of Antibiotic Resistance
1.8K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.8K
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
70
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
70
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
520
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
520
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.8K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.8K

